NCT00766142 2025-08-29
COCHISE
Institut Bergonié
Phase 2 Terminated
Clinical Trials
4 trialsNCT00499031 2015-01-13
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00101192 2014-03-17
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Phase 2 Completed
NCT00392769 2012-09-06
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
M.D. Anderson Cancer Center
Phase 2 Completed